Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. [electronic resource]
- The Journal of clinical endocrinology and metabolism Sep 2006
- 3611-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't